Replies to post #243348 on Biotech Values

[DewDiligence]

VRAX—Congratulations to the children of the CEO and COO as they were the ones who sold stock (not the company).

Actually, VRAX itself realized $7.8M of gross proceeds from selling 1.55M shares in the IPO (https://www.sec.gov/Archives/edgar/data/0001885827/000095017022013443/vrax_6k_uw_consumation.htm
) , but there was a concurrent sale of 1.94M shares by insiders, which is not a promising sign for ordinary shareholders.

Moreover, VRAX hasn’t yet managed its 20-F annual report for the fiscal year ending i3/31/22, which is definitely not a good sign:

https://www.sec.gov/Archives/edgar/data/0001885827/000095017022013497/vrax_nt_20f.htm

Good luck if you invest!